3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine,hydrochloride | CAS:25952-53-8

We serve 3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine,hydrochloride CAS:25952-53-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine,hydrochloride

Chemical Name:3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine,hydrochloride
CAS.NO:25952-53-8
Synonyms:1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride;EDC.HCL
Molecular Formula:C8H18ClN3
Molecular Weight:191.70200
 
Physical and Chemical Properties:
Density:0.877;
Melting point:110-115oC;
Boiling point:269.1oC;
Flash point:107.9oC;
Index of Refraction:1.461;
 
HS Code: 2933990099
 
Specification:
Appearance:White crystal powder
Purity:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:For polypeptide condensing agents and crosslinkers



Contact us for information like 3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine,hydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EDC.HCL physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride Use and application,1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride technical grade,usp/ep/jp grade.


Related News: British Airways, Qantas and Lufthansa — among others — have announced they will stop flying to mainland China. Other airlines are reducing the number of flights.2-thioladenosine manufacturer Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.1-bromo-7-fluoroheptane supplier Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.N-Hydroxymethyl-3,4,5,6-tetrahydrophthalimide vendor CMO services mainly involve four stages: pre-clinical research, clinical trials, sales of patented drugs after listing, and sales of original drug products after patents expire. Its advantages are: lower cost, guaranteed quality, good capacity flexibility, and favorable process Promotion.CMO services mainly involve four stages: pre-clinical research, clinical trials, sales of patented drugs after listing, and sales of original drug products after patents expire. Its advantages are: lower cost, guaranteed quality, good capacity flexibility, and favorable process Promotion.